0Suppliers
4Customers
3Debt Items
3Related Chains

China SXT Pharmaceuticals, Inc. Suppliers

No suppliers on recordChina SXT Pharmaceuticals, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

China SXT Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
SUXUANTANG SUXUANTANG 92% Suxuantang had one significant customer which accounted for 68.72% of our total revenue during the year ended March 31, 2025.
DRUG-STORES DRUG-STORES 90% We currently manufacture 200 Regular TCMP products listed on China Pharmacopoeia (version 2020) Parts I and IV for hospitals and drug stores in treatment of various diseases or serving as dietary sup…
HOSPITALS HOSPITALS 90% We currently manufacture 200 Regular TCMP products listed on China Pharmacopoeia (version 2020) Parts I and IV for hospitals and drug stores in treatment of various diseases or serving as dietary sup…
STREETERVILLE-CAPITAL-LLC STREETERVILLE-CAPITAL-LLC 62% NOTE 10 – BORROWINGS (CONTINUED) Long-term borrowings (Continued) Long-term bank loans are loans the Company borrowed from Jiangsu Taizhou Rural Commercial Bank which are valid from November 2, 2022 …

China SXT Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SXTC-DEBT Debt stack $1.2M 90% Market cache reports total debt of $1.2M.
SXTC-DEBT-12847 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-03-31.
SXTC-DEBT-12846 Warrants outstanding: 0.01 90% xbrl warrant detail from xbrl 2023-09-30.

China SXT Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for China SXT Pharmaceuticals, Inc..

China SXT Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
SXTC-OWNER-CITADEL-ADVISORS-LLC CITADEL ADVISORS LLC 90% 13F overlay lists CITADEL ADVISORS LLC as top holder; 8 tracked holders.

China SXT Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BON Bon Natural Life Limited 100.00 2
WDC Western Digital Corporation 100.00 2
LGCL Lucas GC Limited 36.29 1 ['spend']